What Is a Tesamorelin and Ipamorelin Stack?
Tesamorelin and ipamorelin stack combines two or more compounds in one research plan. This one pairs two peptides that raise growth hormone through different doors.
Tesamorelin is a lab made copy of growth hormone releasing hormone, or GHRH. Ipamorelin belongs to a different family, the growth hormone releasing peptides, which activate the ghrelin receptor. Researchers sometimes call the pairing a GHRH plus GHRP stack.
People also search for tesamorelin ipamorelin stack, and the term describes the same pairing. In short, it combines a hormone mimic with a ghrelin receptor activator.
The Idea Behind Combining Them
The pituitary gland releases growth hormone in pulses. A GHRH analog tells it to release, and a ghrelin receptor activator adds a second signal. In earlier research with other GHRH and GHRP pairs, scientists reported that two signals together raised growth hormone more than either one alone.
Tesamorelin: The Approved Half of the Stack
Tesamorelin is a 44 amino acid peptide that the FDA approved in 2010 under the brand name Egrifta. Doctors prescribe it to reduce excess abdominal fat in adults with HIV associated lipodystrophy.
What the Trials Showed
Two large randomized trials enrolled more than 800 adults with HIV lipodystrophy. Tesamorelin reduced visceral abdominal fat compared with placebo. However, the fat returned within months after people stopped treatment.
Important Limits
The approval covers one population. Researchers have not tested tesamorelin for general weight loss or anti aging in healthy people. The label also notes that about half of patients developed antibodies against it, although the clinical effect of those antibodies varies.
Ipamorelin: The Other Half
Ipamorelin is a small peptide of five amino acids that activates the ghrelin receptor and releases growth hormone. Researchers like it because it appeared more selective than older compounds in its family, with less effect on other hormones such as cortisol.
Where the Evidence Stands
Human data is thin. One mid stage trial tested it for slowed bowel recovery after surgery, and it did not show a clear benefit. No approved use exists. Most claims about ipamorelin come from small studies and user reports.
Tesamorelin and Ipamorelin Stack: What the Research Shows About Combining Them
Here is the plain answer: no controlled trial has tested this exact pair in people. Tesamorelin has strong data on its own in one disease. Ipamorelin has limited data. The combination rests on mechanism and on community reports, which means expectation drives much of what you read online.
Adding CJC-1295: The Three Compound Version
Some sellers add CJC-1295, another GHRH analog, to make a three compound stack. That adds a second GHRH signal on top of tesamorelin, which is already one. Nobody has shown that the extra compound adds benefit, and it adds uncertainty. For a related pairing, see our Ipamorelin and CJC-1295 information.
The Honest Limit of the Evidence
Raising growth hormone is not the same as improving health. Treat the stack as a research tool, not as a proven way to lose fat, build muscle, or slow aging.
Tesamorelin and Ipamorelin Stack: Product Details
Tesamorelin and Ipamorelin Blend Vial
One vial, clearly labeled, with documentation you can check.
Format : lyophilized powder, supplied for reconstitution with bacteriostatic water
Includes : storage reference card, COA with identity and purity data
Delivery : 1 to 2 business days, discreet and tracked
Tesamorelin and Ipamorelin Stack Dosage: Why We Do Not Publish One
This is the most searched topic around the stack. We understand the interest, and we still won’t publish a number.
The only approved tesamorelin regimen belongs to the HIV lipodystrophy label, and doctors prescribe it under supervision. Amounts for the stack come from forums and sellers, and no trial has validated them. Combining two growth hormone signals can also raise IGF 1 more than expected, so guesswork carries real risk.
If you consider use beyond the laboratory, speak with a licensed physician who can monitor blood sugar and IGF 1.
Tesamorelin and Ipamorelin Safety: What to Know First
Growth hormone raising peptides can cause fluid retention, joint pain, numbness or tingling, and higher blood sugar. In trials, tesamorelin also caused injection site reactions.
Pregnant or breastfeeding individuals should not use this stack. People with active cancer or a tumor history should avoid it, because growth hormone and IGF 1 influence cell growth. Anyone with diabetes, pituitary disease, or a history of head or brain tumors should also avoid it without a doctor’s guidance. In addition, athletes should know that anti doping rules prohibit growth hormone releasing compounds. Check the WADA website for current rules.
Tesamorelin vs Ipamorelin vs Sermorelin: A Quick Comparison
| Tesamorelin | Ipamorelin | Sermorelin | |
|---|---|---|---|
| Type | GHRH analog, 44 amino acids | Ghrelin receptor activator, 5 amino acids | GHRH fragment, 29 amino acids |
| Approval status | FDA approved for HIV lipodystrophy | Not approved | Previously approved, now sold through compounding |
| Strongest human evidence | Two large randomized trials | Limited, one mid stage trial | Older clinical history |
| Main research focus | Visceral fat | Growth hormone release | Growth hormone release |
In short, tesamorelin has the strongest evidence of the three, but only for one condition. For details, see our Sermorelin page.
Where to Buy a Tesamorelin and Ipamorelin Stack: What to Check
A search for where to buy this stack returns sellers of very different quality. Because the product is a blend, one purity number can hide a problem, so check each point.
| What to verify | Why it matters |
|---|---|
| Per component identity and purity | It confirms both peptides are present at the stated amounts |
| Lot matched COA | It ties the lab result to your exact batch |
| Clear amount per vial | It lets you verify the label |
| Real support contact | It shows the seller stands behind the product |
We provide each of these on every batch. Browse our full peptide catalog to compare other compounds.
Tesamorelin and Ipamorelin Regulatory Status in 2026
The FDA has approved tesamorelin only as the prescription product Egrifta. Ipamorelin is not approved. Rules for research compounds and compounded peptides change often, so read the FDA compounding guidance before you buy.
Ready to Order the Tesamorelin and Ipamorelin Stack?
You now know what each peptide does, what the trials covered, and what the combination lacks. The last step is the source, and that choice decides what arrives at your door.
Every vial ships with a lot matched COA. Orders placed before 2pm ship the same day, and a real team member answers every question.
Buy the Blend: $200
Questions Before You Order? Contact Us
Frequently Asked Questions: Tesamorelin and Ipamorelin Stack
What is a tesamorelin and ipamorelin stack?
It pairs tesamorelin, a GHRH analog, with ipamorelin, a ghrelin receptor activator. Both raise growth hormone through different signals.
Is tesamorelin FDA approved?
Yes, as Egrifta, for reducing excess abdominal fat in adults with HIV associated lipodystrophy. It is not approved for general weight loss.
Is ipamorelin FDA approved?
No. Human data is limited, and no approved use exists.
Does the stack work better than tesamorelin alone?
No controlled trial has compared them. The idea comes from mechanism and from research on other peptide pairs.
What is the tesamorelin and ipamorelin stack dosage?
No validated dose exists for the combination, so we do not publish dosing protocols. Anyone considering use outside a laboratory should consult a licensed physician.
Should I add CJC-1295?
No trial shows that a third compound adds benefit. It adds another GHRH signal and more uncertainty.
What are the side effects?
Reported effects include fluid retention, joint pain, tingling, higher blood sugar, and injection site reactions.
Who should avoid it?
Pregnant or breastfeeding individuals, people with cancer or a tumor history, and people with diabetes or pituitary disease should avoid it without medical guidance.
Is it banned in sports?
Yes. Anti doping rules prohibit growth hormone releasing compounds, so athletes who are tested should avoid them.
How should I store the blend?
Keep unopened vials cold and away from light, and follow the storage card in your package. After reconstitution, keep the solution refrigerated and use it within the window stated on the card.
Where can I buy this stack?
You can order it from our store with a lot matched COA. Whichever seller you choose, verify per component identity and purity.
| Format | Tesamorelin 10 mg + Ipamorelin 5 mg |
|---|







Reviews
There are no reviews yet.